About Aragen Life Sciences
Aragen Life Sciences is a company based in Hyderabad (India) founded in 2001. It operates as a Professional Services and Managed Services. Aragen Life Sciences has raised $195.65 million across 5 funding rounds from investors including Goldman Sachs, Avendus and Quadria Capital. The company has 3,859 employees. Aragen Life Sciences has completed 3 acquisitions, including Aragen Bioscience, INTOX lab and Vanta Bioscience. Aragen Life Sciences offers products and services including Small Molecules and Large Molecules (Biologics). Aragen Life Sciences operates in a competitive market with competitors including Hybio Pharmaceutical, Nephron Pharmaceuticals, Suanfarma, Aiolos Bio and Kardigan, among others.
- Headquarter Hyderabad, India
- Employees 3,859
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website aragen.com
- Social LinkedIn Facebook Instagram YouTube
- Legal Name Aragen Life Sciences Ltd.
- Date of Incorporation 07 Dec, 2000
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1,870 Cr
FY 2025 · +12% YoY
- Net Profit₹180 Cr
FY 2025 · 10% margin
- EBITDA₹478 Cr
FY 2025 · 26% margin
- Total Equity Funding$195.65M (USD)
in 5 rounds
- Latest Funding Round$36M (USD), Private Equity Round
Aug 2025
- InvestorsGoldman Sachs
& 3 more
- Employee Count3,859
- Investments & AcquisitionsAragen Bioscience
& 2 more
Associated legal entities of Aragen Life Sciences
Aragen Life Sciences is associated with 2 registered companies on The Company Check; the primary company is Aragen Life Sciences Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Aragen Life Sciences Limited CIN U74999TG2000PLC035826 | Active | 07 Dec 2000 | Hyderabad, Telangana | ₹1,870 Cr | 3,859 | 12 | View details |
| Gvk Davix Technologies Private Limited CIN U74110TG2005PTC045481 | Amalgamated | 25 Feb 2005 | Hyderabad, Telangana | ₹1,300 Cr | – | 5 | View details |
Products & Services of Aragen Life Sciences
Aragen Life Sciences offers a comprehensive portfolio of products and services, including Small Molecules and Large Molecules (Biologics).
Small molecules are developed and manufactured for pharmaceuticals.
Biologics solutions are provided from gene to clinic.
Apps and channels of Aragen Life Sciences
its YouTube channel Aragen Life Sciences has 669 subscribers and 22 videos.
Videos from Aragen Life Sciences
The most watched videos on Aragen Life Sciences's YouTube channel, Aragen Life Sciences (669 subscribers). Click a video to play it here.
More on Aragen Life Sciences.
Funding Insights of Aragen Life Sciences
Aragen Life Sciences has successfully raised a total of $195.65M across 5 strategic funding rounds. The most recent funding activity was a Private Equity Round of $36 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $195.65M
- Total Rounds 5
- Last Round Private Equity Round — $36M
- First Round $25.45M
(Nov 2007)
- Investors Count 4
All 5 funding rounds of Aragen Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | $36M | Private Equity Round | – | – | |
| Aug 2025 | $34.2M | Series C | – | Avendus | – |
| Jan 2025 | $100M | Private Equity Round | – | – | |
| May 2021 | – | Series B | – | Goldman Sachs | – |
| Nov 2007 | $25.45M | Series B | $272.82M | Sequoia Capital | – |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2007 | $272.82M | •••••••• |
Last known valuation $272.82M (Nov 2007). 4 investors in total: 4 institutional.
Investors in Aragen Life Sciences
Aragen Life Sciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Avendus and Quadria Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare private equity investments focused on Asian markets. | 2012 | quadriacapital.com | Singapore, Singapore | |
Investment banking services are delivered across multiple financial sectors. | 1869 | goldmansachs.com | New York, United States | |
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | - | |
Corporate advisory and investment services are provided to clients. | 1999 | avendus.com | Mumbai, India |
Investor details for Aragen Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Aragen Life Sciences Limited (Aragen Life Sciences)
Aragen Life Sciences Limited is the primary company behind Aragen Life Sciences. The boards of the 2 registered companies of Aragen Life Sciences currently have 12 directors; the longest-serving is Venkata Krishna Reddy Gunupati, appointed in 2005. 21 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Krishna Reddy Gunupati DIN 00005212 | Director | 25 Feb 2005 | 21 yrs 7 mo | Gvk Davix Technologies Private Limited |
| Venkata Sanjayreddy Gunupati DIN 00005282 | Director | 25 Feb 2005 | 21 yrs 7 mo | Gvk Davix Technologies Private Limited |
| Davinder Singh Brar DIN 00068502 | Director | 25 Feb 2005 | 21 yrs 7 mo | Gvk Davix Technologies Private Limited, Aragen Life Sciences Limited |
| Indira Krishna Reddy Gunupati DIN 00005230 | Director | 30 Sep 2005 | 21 yrs | Gvk Davix Technologies Private Limited |
| Manmahesh Kantipudi DIN 05241166 | Managing Director | 29 May 2018 | 8 yrs 4 mo | Aragen Life Sciences Limited |
| Robert Richard Ruffolo DIN 08404004 | Director | 17 Apr 2019 | 7 yrs 5 mo | Aragen Life Sciences Limited |
| Gunapati Reddy Venkat Keshav DIN 06593325 | Director | 30 Jan 2020 | 6 yrs 8 mo | Aragen Life Sciences Limited |
| Rajat Sood DIN 07914803 | Director | 19 May 2021 | 5 yrs 4 mo | Aragen Life Sciences Limited |
| Ajay Srivastava DIN 00049912 | Director | 20 May 2021 | 5 yrs 4 mo | Aragen Life Sciences Limited |
| Anita Ramachandran DIN 00118188 | Director | 07 Nov 2022 | 3 yrs 11 mo | Aragen Life Sciences Limited |
| Sachin Anand Dharap DIN 00785700 | CFO | 25 Jan 2023 | 3 yrs 8 mo | Aragen Life Sciences Limited |
| Amit Varma DIN 02241746 | Director | 09 Jan 2025 | 1 yr 9 mo | Aragen Life Sciences Limited |
People of Aragen Life Sciences
232 people are tracked at Aragen Life Sciences (82 in leadership, 7 in board & advisors, 143 in team); the tracked headcount is 3,859.
| Name | Role | Group |
|---|---|---|
Manni Kantipudi | CEO | Leadership |
Suveer Shrivastava | Sr. VP & Head Corporate Quality And Regulatory Affairs | Leadership |
Sreekala Nair | Director | Leadership |
Dr Vinod Jadhav | Senior Director | Leadership |
Manoj Bisht | Associate Vice President | Leadership |
Krishna Ethiraj | Senior Vice President & Site Head, Chemistry Services, Hyderabad | Leadership |
Dr. Nagesh Chidalla | Associate Director | Leadership |
Sagar Patil | GM & Sbu Head (entrepreneur) | Leadership |
| Chief Financial Officer | Leadership | |
Suresh Anubolu | Chief Human Resources Officer | Leadership |
Girish Joshi | Vice President & BU Head - Safety Assessment Solutions | Leadership |
Subodh Deshmukh | CEO, Biologics & President, Development & Manufacturing | Leadership |
Gokul Ram | Head Of Quality Control Biologics | Leadership |
Kevin Pattamana | Senior Director Business Development | Leadership |
Maheshwar Bole | Associate Director -api Sales & Marketing | CMS Global Sales | Leadership |
Amar Karandikar | Sr VP Business Development | Leadership |
Indraneel Sanyal | Senior Director | Leadership |
Swapnil Wadhwa | Chief Digital & Information Officer (cdio) @ Aragen Digital X (adx) | Leadership |
Keshav Vasanthavada | Global Head Of Business Development, Biologics Services | Leadership |
Ashu Tandon | Chief Commercial Officer (cco) | Leadership |
212 more people are available in the full profile.
Complete people profiles for Aragen Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Aragen Life Sciences
Figures of Aragen Life Sciences Limited, the primary company behind Aragen Life Sciences, for FY 2025. Revenue was ₹1,870 Cr (+12% year on year). Net profit was ₹180 Cr (10% margin). EBITDA was ₹478 Cr (26% margin). Revenue has grown at a compounded annual rate of +10% over three years and +14% over five years.
- ₹1,870 CrRevenue · FY 2025 · +12% YoY
- ₹180 CrNet profit · 10% margin
- ₹478 CrEBITDA · 26% margin
- ₹217 CrPaid-up capital
- 3,859Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Aragen Life Sciences Limited are on its company page.
Detailed financial statements for Aragen Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aragen Life Sciences
Aragen Life Sciences has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aragen Bioscience, INTOX lab and Vanta Bioscience.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Preclinical contract research services in toxicology are offered. | intoxlab.com | Pune, India | 1995 | Dec 2021 | •••• | |
GLP-certified preclinical contract research services are provided. | vantabio.com | Chennai, India | 2010 | Nov 2014 | •••• | |
CRO offering cell line development, protein and antibody production, in vivo models of human disease and safety studies. | aragenbio.com | Morgan Hill, United States | 1993 | Jan 2014 | •••• |
Complete acquisition details for Aragen Life Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Aragen Life Sciences
7 dated milestones of Aragen Life Sciences across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Aragen Life Sciences is founded.
- Funding First funding round of $25.4M.
- Milestone Reaches Minicorn status.
- Acquisition Acquires Aragen Bioscience.
- Acquisition Acquires Vanta Bioscience.
- Acquisition Acquires INTOX lab.
- Funding Latest funding round, Private Equity Round, of $36.0M.
Competitors of Aragen Life Sciences
Aragen Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hybio Pharmaceutical, Nephron Pharmaceuticals, Suanfarma, Aiolos Bio and Kardigan, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hybio.com.cn | 1998 | Shenzhen, China | $15M | – | Polypeptide drugs and APIs are developed and manufactured. | |
| nephronpharm.com | 1937 | Florida, Puerto Rico | $625M | 1,578 | Sterile pharmaceutical products are manufactured and contract services are provided. | |
| suanfarma.com | 1993 | Madrid, Spain | – | – | Generics, nutraceuticals, and APIs are developed by Suanfarma. | |
| aiolosbio.com | 2023 | Boston, United States | $245M | – | Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions | |
| kardigan.bio | 2023 | San Francisco, United States | $554M | – | Biotech company developing personalized medicines for cardiovascular diseases | |
| ambiopharm.com | 2006 | North Augusta, United States | $24M | 186 | CDMO and analytical services for peptide development are provided. | |
| wheelerbio.com | 2020 | Oklahoma, United States | $103.15M | – | Provider of drug research and analytical development services for multiple therapeutic areas | |
| onesourcecdmo.com | 2023 | Bengaluru, India | – | 567 | Pharmaceutical contract development and manufacturing services are offered by OneSource. |
Detailed competitors of Aragen Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aragen Life Sciences
The website of Aragen Life Sciences (aragen.com) receives about 19.7K visits a month and ranks #1,876,396 among all websites worldwide, #2,564 in Biotechnology and Pharmaceuticals.
- Monthly visits19.7K
▲ 45.8% vs previous month
- Unique visitors6.4K
per month
- Global rank#1,876,396
among all websites
- Category rank#2,564
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit1.6
- Average visit51 sec
- DevicesDesktop 37% · Mobile 63%
Websites whose visitors overlap most with Aragen Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| jubilantbiosys.com | 100% | 12.2K | #2,731,637 | View details |
Latest news on Aragen Life Sciences
Complete news archive for Aragen Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Aragen Life Sciences
10 companies that operate in the same segment as Aragen Life Sciences (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aragen Life Sciences
Aragen Life Sciences was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Aragen Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Manni Kantipudi is the current CEO of Aragen Life Sciences.
Aragen Life Sciences is a funded company, having raised a total of $195.65M across 5 funding rounds to date. The company's 1st funding round was a Series B of $25.45M, raised on Nov 2007.
Aragen Life Sciences has 3,859 employees.
The primary company behind Aragen Life Sciences, Aragen Life Sciences Limited, reported revenue of ₹1,870 Cr for FY 2025, up 12% year on year.
Aragen Life Sciences is involved in providing contract research, development, and manufacturing solutions for the pharmaceutical and biotech industries. Services are offered in small molecules and large molecules (biologics), covering discovery, development, and production. Operations are conducted across multiple global locations in Asia, North America, and Europe. Innovative solutions are delivered to support clients from concept to commercial stages. A focus is maintained on quality, sustainability, and intellectual property protection.
Aragen Life Sciences's top competitors include Nephron Pharmaceuticals, Suanfarma and Hybio Pharmaceutical.
Aragen Life Sciences offers Small Molecules and Large Molecules (Biologics).
Aragen Life Sciences has made 3 acquisitions, including Aragen Bioscience, INTOX lab, and Vanta Bioscience.
Aragen Life Sciences has 4 investors. Key investors include Goldman Sachs, Avendus, Quadria Capital, and Sequoia Capital.
The valuation of Aragen Life Sciences is $272.82M as of Nov 2007.